cyclosporine and Bowel Diseases, Inflammatory

cyclosporine has been researched along with Bowel Diseases, Inflammatory in 101 studies

Research

Studies (101)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	29 (28.71)	18.2507
2000's	40 (39.60)	29.6817
2010's	26 (25.74)	24.3611
2020's	6 (5.94)	2.80

Authors

Authors	Studies
Abramov-Harpaz, K; Aponick, A; Ben-Shabat, S; Dahan, A; Markovic, M; Miller, Y; Regev, C; Zimmermann, EM	1
Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Farley Prater, EA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Wong, EB; Wu, JJ	1
Desai, N; Momin, M	1
Amariglio, N; Ben-Horin, S; Chen, MH; Chowers, Y; Eliakim, R; Fudim, E; Kopylov, U; Levhar, N; Mao, R; Picard, O; Shemer-Avni, Y; Ungar, B; Yavzori, M; Ye, Z	1
Aponick, A; Ben-Shabat, S; Dahan, A; Manda, JN; Markovic, M; Zimmermann, EM	1
Bouhnik, Y; Maggiori, L; Mege, D; Monsinjon, M; Panis, Y; Treton, X	1
Carreras, JJ; Draheim, C; Garrigues, TM; Giner, E; Giner, R; Hansen, S; Lehr, CM; Melero, A; Peris, JE; Recio, MC; Talens-Visconti, R	1
Estévez-Boullosa, P; Fernández-Fernández, N; Martínez-Cadilla, J; Pineda-Mariño, JR; Posada-García, C; Rodríguez-Prada, JI	1
Bettenay, SV; Classen, J; Dengler, B; Klinger, CJ; Mueller, RS; Rickerts, V	1
Falk, W; Hauschildt, S; Hoffmann, M; Lehmann, J; Schwertassek, U; Seydel, A; Weber, K	1
Farkas, K; Molnár, T; Szántó, K	1
Kandolf-Sekulović, L; Mijušković, Ž; Milenković, Z; Pecelj-Broćić, T; Tarabar, D; Tarabar, O; Tatomirović, Ž	1
Armstrong, AW; Enos, CW; Gottlieb, A; Langley, RG; Lebwohl, M; Merola, JF; Ryan, C; Siegel, MP; Van Voorhees, AS; Weinberg, JM; Whitlock, SM; Wu, JJ	1
Christensen, B; Cohen, RD; Colman, RJ; Gibson, PR; Goeppinger, SR; Kassim, O; Micic, D; Rubin, DT; Weber, CR; Yarur, A	1
Buchholz, BM; Fusai, GK; Lykoudis, PM; Pollok, JM; Ravikumar, R	1
De' Angelis, GL; Di Mario, F; Fusco, C; Gaiani, F; Leandro, G; Pisani, F; Spagnoli, C	1
Fernandez, AP; Hu, JZ; Husni, ME; Mazloom, SE; Warren, CB; Ya, J; Yan, D	1
Habal, FM; Huang, VW	1
López-González, R; Martín-Martínez, MA; Pérez-Vicente, S; Silva-Fernández, L	1
Boey, CC; Chong, SY; Khoh, KM; Lee, WS; Lim, CB; Lum, SH; Ng, RT; Pailoor, J; Teo, KM	1
Aloi, M; Birimberg-Schwartz, L; Bronsky, J; Buderus, S; Fell, JM; Hojsak, I; Koletzko, S; Miele, E; Russell, RK; Shaoul, R; Turner, D; Veereman, G	1
Kraas, L; Quist, SR	1
Annese, V; Ardizzone, S; Armuzzi, A; Biancone, L; Calabrese, E; Caprioli, F; Castiglione, F; Comberlato, M; Cottone, M; D'Incà, R; Danese, S; Daperno, M; Frieri, G; Fries, W; Gionchetti, P; Kohn, A; Latella, G; Meucci, G; Milla, M; Orlando, A; Papi, C; Petruzziello, C; Riegler, G; Rizzello, F; Saibeni, S; Scribano, ML; Vecchi, M; Vernia, P	1
Bollea-Garlatti, ML; Galimberti, RL; Torre, AC; Vacas, AS; Warley, F	1
Feagan, B; Ghosh, S; Panaccione, R; Rutgeerts, P; Sandborn, WJ; Schreiber, S	1
Rogler, G	1
Cullen, G; Keegan, D; O'Donoghue, D	1
Van Assche, G	1
Cury, DB; Moss, AC	1
Cardoso, CR; Cunha, FQ; Ferraz, DB; Godoi, DF; Provinciatto, PR; Silva, JS; Voltarelli, JC	1
Kapsoritakis, AN; Oikonomou, KA; Potamianos, SP; Stefanidis, I	1
Ahrens, ET; Kadayakkara, DK; Ranganathan, S; Young, WB	1
Actis, GC; Pellicano, R; Rizzetto, M; Rosina, F	1
Chiba, T; Matsuura, M; Nakase, H	1
Stange, EF	1
Erichsen, Jv; Hessmann, M; Hoffmeyer, A; Pahl, A; Sann, H	1
Barabino, A; Calvi, A; Castellano, E; Cucchiara, S; De Giacomo, C; De, GL; Fontana, M; Gandullia, P; Gissi, A; Lionetti, P; Torrente, F	1
Lashner, BA; Wolf, JM	1
Ferrero, S; Ragni, N	1
Chowers, Y; Eliakim, R; Lavy, A; Odes, HS	1
Hanauer, SB; Present, DH	1
Kornbluth, A	2
Fellermann, K; Lühmann, D; Stange, EF	1
Sachar, DB	1
Dijkstra, G; Haagsma, EB; Kleibeuker, JH; Slooff, MJ; Van Den Berg, AP	1
Fatome, A; Lebreton, G	1
Ardizzone, S; Bianchi Porro, G; Carsana, L; Cristaldi, M; Danelli, P; Maconi, G; Sampietro, GM	1
Angeloni, G; Gasbarrini, G; Latteri, M; Manna, R; Navarra, P; Rumi, C	1
Chaput, JC; Decaens, T; Maitre, S; Marfaing, A; Mathurin, P; Naveau, S	1
Egan, LJ; Loftus, CG; Sandborn, WJ	1
Friedman, S	1
Dejaco, C; Knoflach, P; Petritsch, W; Reinisch, W; Tilg, H; Vogelsang, H	1
Angelucci, E; Caprilli, R; Cocco, A; Viscido, A; Zippi, M	1
Ando, T; Goto, H; Hibi, K; Ina, K; Kusugami, K; Nishio, Y	1
Siegmund, B; Zeitz, M	1
Aberra, FN; Lichtenstein, GR	1
Matsui, T	1
Abreu, MT; Cohen, R; Lichtenstein, GR; Tremaine, W	2
Kang, JY; Kumar, D; Pollok, RC; Subramanian, V	1
Hibi, T; Ogata, H	1
Guardiola, J; Rodríguez-Moranta, F; Soriano-Izquierdo, A	1
George, J; Kornbluth, A; Lichtiger, S; Murphy, SJ; Present, DH; Sternthal, MB	1
Kornbluth, A; Swaminath, A	1
Jansson, L; Karlsson, A; Karlsson, L; Melgar, S; Michaëlsson, E; Rehnström, E; Utkovic, H	1
Brazier, F; Duchmann, JC; Dupas, JL; Finet, L	1
Sandborn, WJ	2
Crippin, J; Goldstein, R; Gonwa, TA; Holman, M; Husberg, B; Klintmalm, G; Stephens, J	1
Bernstein, CN; Shanahan, F	1
La Tulippe Naccarini, DA; Minor, ML	1
Brynskov, J	1
Daum, F; Grancher, K; Mandel, F; Markowitz, J	1
Kozarek, RA	1
Korelitz, BI	2
Calenda, K; Grand, RJ; Langhans, N; Ramakrishna, J; Verhave, M	1
van Hogezand, RA; Verspaget, HW	1
Lichtenstein, GR; Stotland, BR	1
Tremaine, WJ	1
Roy, MA	1
van Deventer, SJ	1
Aranda, R; Horgan, K	1
Colomina Avilés, J; Del Pino Cuadrado, J; García García, A; Ortuño Cortés, J; Pascual Pérez, R	1
Balow, JE; James, SP; Klippel, JH; Langford, CA; Sneller, MC	1
Meijssen, MA	1
Altomare, G; Capella, GL; Fracchiolla, C; Frigerio, E	1
Hanauer, SB; Stein, RB	1
Baert, F; Rutgeerts, P	1
Colombel, JF; Desreumaux, P; Ectors, N; Geboes, K; Jouret, A; Rutgeerts, P	1
Cherikuri, A; Donnelly, S; Farrell, RJ; Keeling, PW; Kelleher, D; Long, A; Mahmud, N; Murphy, A; O'Toole, D; Weir, DG	1
Ewe, K; Gassull, MA; Geboes, K; Jewell, D; Meuwissen, SG; Pallone, F; Rachmilewitz, D; Rask-Madsen, J; Riddell, BH; Sandborn, BJ; Schmuck, ML	1
Chicharro, Mf; Guarner, L; Malagelada, J; Planas, M; Vilaseca, J	1
Haslam, N; Hearing, SD; Probert, CS	1
Friedman, S; Marion, JF; Present, DH; Rubin, PH; Scherl, E	1
Angeloni, G; Gasbarrini, G; Latteri, M; Manna, R; Navarra, P; Silveri, NG	1
Doe, WF; Elsbury, S; Hapel, AJ; Kobayashi, M; Pullman, WE	1
Doe, WF; Pullman, WE	1
Hodgson, HJ	1

Reviews

47 review(s) available for cyclosporine and Bowel Diseases, Inflammatory

Article	Year
Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:2 Topics: Acitretin; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Certolizumab Pegol; Cyclosporine; Dermatologic Agents; Etanercept; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Infliximab; Psoriasis; Thalidomide; Ustekinumab	2018
Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients. World journal of gastroenterology, 2018, Jul-28, Volume: 24, Issue:28 Topics: Cholangitis, Sclerosing; Colectomy; Colon; Cyclosporine; Dysbiosis; Gastrointestinal Microbiome; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Transplantation; Perioperative Care; Risk Assessment; Risk Factors; Secondary Prevention; Tacrolimus; Treatment Outcome	2018
Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association. Acta bio-medica : Atenei Parmensis, 2018, 12-17, Volume: 89, Issue:9-S Topics: Antibodies, Monoclonal; Antirheumatic Agents; Campylobacter Infections; Celiac Disease; Child; Comorbidity; Cyclosporine; Diet, Gluten-Free; Electrophysiology; Gastrointestinal Diseases; Genetic Predisposition to Disease; Guillain-Barre Syndrome; Humans; Inflammatory Bowel Diseases; Intestinal Pseudo-Obstruction; Malnutrition; Micronutrients; Muscular Dystrophy, Oculopharyngeal; Ophthalmoplegia; Peripheral Nervous System Diseases; Quality of Life; Thalidomide	2018
From conception to delivery: managing the pregnant inflammatory bowel disease patient. World journal of gastroenterology, 2014, Apr-07, Volume: 20, Issue:13 Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Anti-Bacterial Agents; Azathioprine; Biological Products; Breast Feeding; Cyclosporine; Female; Fertility; Humans; Inflammatory Bowel Diseases; Maternal Exposure; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications; Sulfasalazine	2014
Treatment options for pyoderma gangrenosum. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2017, Volume: 15, Issue:1 Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Biological Products; Comorbidity; Cyclosporine; Diagnosis, Differential; Humans; Immunity, Innate; Immunization, Passive; Immunosuppressive Agents; Inflammatory Bowel Diseases; Injections, Intralesional; Multicenter Studies as Topic; Pyoderma Gangrenosum; Randomized Controlled Trials as Topic; Rare Diseases; Retrospective Studies	2017
Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics, 2008, Sep-15, Volume: 28, Issue:6 Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Adult; Algorithms; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Child; Clinical Protocols; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Intestinal Mucosa; Mercaptopurine; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction; Severity of Illness Index	2008
[Benefits and risks of immunosuppression in chronic inflammatory bowel diseases]. Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:38 Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Quality of Life; Remission Induction; Risk Assessment; Risk Factors	2008
Optimizing the benefit to risk ratio of medical therapy of inflammatory bowel diseases. Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 2008, Volume: 70, Issue:5-6 Topics: Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Recurrence; Remission Induction; Risk Assessment	2008
Drug-induced nephrotoxicity in inflammatory bowel disease. Nephron. Clinical practice, 2011, Volume: 119, Issue:2 Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Kidney Diseases; Tumor Necrosis Factor-alpha	2011
An aggressive medical approach for inflammatory bowel disease: clinical challenges and therapeutic profiles in a retrospective hospital-based series. Current clinical pharmacology, 2012, Volume: 7, Issue:3 Topics: Adolescent; Adult; Aged; Azathioprine; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Hospitalization; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Retrospective Studies; Young Adult	2012
Inflammatory bowel disease: sorting out the treatment options. Cleveland Clinic journal of medicine, 2002, Volume: 69, Issue:8 Topics: Anti-Inflammatory Agents; Azathioprine; Clinical Trials as Topic; Cyclosporine; Fish Oils; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Practice Guidelines as Topic; Steroids; Sulfasalazine	2002
Inflammatory bowel disease: management issues during pregnancy. Archives of gynecology and obstetrics, 2004, Volume: 270, Issue:2 Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Breast Feeding; Contraindications; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Maternal Nutritional Physiological Phenomena; MEDLINE; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome	2004
The state of the art in the management of inflammatory bowel disease. Reviews in gastroenterological disorders, 2003,Spring, Volume: 3, Issue:2 Topics: Administration, Oral; Adrenal Cortex Hormones; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Intestinal Mucosa; Long-Term Care; Male; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Sulfasalazine; Treatment Outcome	2003
Is there still a role for cyclosporine in the treatment of inflammatory bowel disease? Pro argument. Inflammatory bowel diseases, 2003, Volume: 9, Issue:3 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases	2003
Is there still a role for cyclosporine in the treatment of inflammatory bowel disease? Con argument. Inflammatory bowel diseases, 2003, Volume: 9, Issue:3 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Meta-Analysis as Topic	2003
[Management of severe acute colitis]. Journal de chirurgie, 2003, Volume: 140, Issue:4 Topics: Acute Disease; Adrenal Cortex Hormones; Algorithms; Case Management; Colectomy; Colitis; Colonoscopy; Cyclosporine; Humans; Ileostomy; Immunosuppressive Agents; Inflammatory Bowel Diseases	2003
Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease. Gastroenterology clinics of North America, 2004, Volume: 33, Issue:2 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mycophenolic Acid; Tacrolimus	2004
General principles of medical therapy of inflammatory bowel disease. Gastroenterology clinics of North America, 2004, Volume: 33, Issue:2 Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Quality of Life	2004
Efficacy of conventional immunosuppressive drugs in IBD. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2004, Volume: 36, Issue:11 Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Mycophenolic Acid; Tacrolimus; Thalidomide	2004
Immunomodulatory therapy for inflammatory bowel disease. Journal of gastroenterology, 2004, Volume: 39, Issue:12 Topics: Antibodies, Monoclonal; Cyclosporine; Cytoprotection; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Immunotherapy; Inflammatory Bowel Diseases; Infliximab; Leukapheresis	2004
Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis. Roczniki Akademii Medycznej w Bialymstoku (1995), 2004, Volume: 49 Topics: Antibodies, Monoclonal; Azathioprine; Cell Adhesion; Cell Movement; Cyclophosphamide; Cyclosporine; Gastrointestinal Agents; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Interleukin-10; Interleukin-12; Interleukin-18; Interleukins; Methotrexate; Oligodeoxyribonucleotides, Antisense; Phosphorothioate Oligonucleotides; Thionucleotides; Treatment Outcome; Tumor Necrosis Factor-alpha	2004
Review article: monitoring of immunomodulators in inflammatory bowel disease. Alimentary pharmacology & therapeutics, 2005, Feb-15, Volume: 21, Issue:4 Topics: Azathioprine; Cyclosporine; Drug Monitoring; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate	2005
[New therapies for inflammatory bowel disease]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2005, Volume: 102, Issue:7 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytapheresis; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Male; Tacrolimus	2005
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology, 2006, Volume: 130, Issue:3 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid; Recurrence	2006
Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators. The British journal of surgery, 2006, Volume: 93, Issue:7 Topics: Aged; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Middle Aged; Postoperative Complications; Risk Factors	2006
[Inflammatory bowel disease: current progress and future aspect]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2007, Volume: 104, Issue:8 Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Forecasting; Humans; Immunotherapy; Inflammatory Bowel Diseases; Infliximab; Leukapheresis; Point Mutation; T-Lymphocytes, Cytotoxic	2007
[Current status of treatment of inflammatory bowel disease]. Cirugia espanola, 2007, Volume: 82, Issue:5 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Certolizumab Pegol; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colectomy; Colitis, Ulcerative; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Infusions, Intravenous; Mercaptopurine; Meta-Analysis as Topic; Polyethylene Glycols; Quality of Life; Rectal Fistula; Recurrence; Time Factors	2007
Optimizing drug therapy in inflammatory bowel disease. Current gastroenterology reports, 2007, Volume: 9, Issue:6 Topics: Absorptiometry, Photon; Adalimumab; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Cyclosporine; Humans; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Mesalamine; Patient Compliance; Prednisone; Treatment Failure	2007
[Cyclosporine A and chronic inflammatory diseases of the digestive tract]. Gastroenterologie clinique et biologique, 1995, Volume: 19, Issue:5 Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Inflammatory Bowel Diseases	1995
Cyclosporin for inflammatory bowel disease: mechanisms and possible actions. Scandinavian journal of gastroenterology, 1993, Volume: 28, Issue:10 Topics: Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Administration Routes; Humans; Inflammatory Bowel Diseases; Kidney; Lymphocyte Activation; T-Lymphocytes; Time Factors	1993
Review article: immunosuppressive therapy for inflammatory bowel disease. Alimentary pharmacology & therapeutics, 1993, Volume: 7, Issue:2 Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate	1993
My thoughts on using cyclosporine in the treatment of inflammatory bowel disease. The American journal of gastroenterology, 1995, Volume: 90, Issue:12 Topics: Clinical Trials as Topic; Cyclosporine; Humans; Inflammatory Bowel Diseases	1995
A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. The American journal of gastroenterology, 1996, Volume: 91, Issue:3 Topics: Algorithms; Azathioprine; Controlled Clinical Trials as Topic; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate	1996
Selective immunomodulation in patients with inflammatory bowel disease--future therapy or reality? The Netherlands journal of medicine, 1996, Volume: 48, Issue:2 Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytokines; Humans; Immunosuppressive Agents; Immunotherapy; Inflammatory Bowel Diseases; Intestinal Mucosa	1996
Newer treatments for inflammatory bowel disease. Primary care, 1996, Volume: 23, Issue:3 Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Nutritional Physiological Phenomena	1996
Refractory IBD: medical management. The Netherlands journal of medicine, 1997, Volume: 50, Issue:2 Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-10; Methotrexate	1997
Inflammatory bowel disease. The Surgical clinics of North America, 1997, Volume: 77, Issue:6 Topics: Abdomen, Acute; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Diagnosis, Differential; Emergencies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Perforation; Megacolon, Toxic; Prognosis; Survival Rate	1997
Review article: Chemokine production by intestinal epithelial cells: a therapeutic target in inflammatory bowel disease? Alimentary pharmacology & therapeutics, 1997, Volume: 11 Suppl 3 Topics: Animals; Anti-Inflammatory Agents; Cell Line; Chemokines, CC; Chemokines, CXC; Cyclosporine; Dexamethasone; Epithelial Cells; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Neutrophil Activation	1997
Immunosuppressive drugs in the treatment of inflammatory bowel disease. Seminars in gastrointestinal disease, 1998, Volume: 9, Issue:1 Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate	1998
[Cyclosporine in inflammatory bowel disease]. Anales de medicina interna (Madrid, Spain : 1984), 1998, Volume: 15, Issue:4 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases	1998
Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity. Annals of internal medicine, 1998, Jul-01, Volume: 129, Issue:1 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Vasculitis	1998
Cyclosporine and inflammatory bowel disease: buying time. Mediators of inflammation, 1998, Volume: 7, Issue:3 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases	1998
Medical therapy for inflammatory bowel disease. Gastroenterology clinics of North America, 1999, Volume: 28, Issue:2 Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Recurrence; Salicylates; Severity of Illness Index; Steroids	1999
New strategies in the management of inflammatory bowel disease. Acta clinica Belgica, 1999, Volume: 54, Issue:5 Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Glucocorticoids; Humans; Immunity, Mucosal; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Prevalence; Tumor Necrosis Factor-alpha	1999
[Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores]. Gastroenterologie clinique et biologique, 1999, Volume: 23, Issue:10 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; Colitis, Ulcerative; Colon; Crohn Disease; Cyclosporine; Humans; Hydroxyurea; Ileum; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Microscopy; Sulfasalazine; Time Factors	1999
Cyclosporine in inflammatory bowel disease. Current gastroenterology reports, 1999, Volume: 1, Issue:6 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Quality of Life	1999
Cyclosporin in inflammatory bowel disease. Alimentary pharmacology & therapeutics, 1991, Volume: 5, Issue:4 Topics: Animals; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Inflammatory Bowel Diseases	1991

Trials

1 trial(s) available for cyclosporine and Bowel Diseases, Inflammatory

Article	Year
Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease. Journal of pediatric gastroenterology and nutrition, 1996, Volume: 22, Issue:3 Topics: Adolescent; Azathioprine; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Inflammatory Bowel Diseases; Male; Mercaptopurine; Remission Induction; Treatment Outcome	1996

Article

Year

Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease.

Journal of pediatric gastroenterology and nutrition, 1996, Volume: 22, Issue:3

Topics: Adolescent; Azathioprine; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Inflammatory Bowel Diseases; Male; Mercaptopurine; Remission Induction; Treatment Outcome

1996

Other Studies

53 other study(ies) available for cyclosporine and Bowel Diseases, Inflammatory

Article	Year
Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA International journal of molecular sciences, 2022, Feb-28, Volume: 23, Issue:5 Topics: Cyclosporine; Humans; Inflammatory Bowel Diseases; Phospholipases A2; Phospholipids; Prodrugs	2022
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:1 Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Biological Products; Calcineurin Inhibitors; Cardiovascular Diseases; Child; Child, Preschool; Coal Tar; Comorbidity; Cyclosporine; Dermatologic Agents; Dyslipidemias; Evidence-Based Medicine; Humans; Infant; Infant, Newborn; Inflammatory Bowel Diseases; Insulin Resistance; Mental Health; Metabolic Syndrome; Methotrexate; Nicotinic Acids; Obesity; Photochemotherapy; Psoriasis; Retinoids	2020
Colon targeted bioadhesive pellets of curcumin and cyclosporine for improved management of inflammatory bowel disease. Drug delivery and translational research, 2020, Volume: 10, Issue:5 Topics: Animals; Colitis; Colon; Curcumin; Cyclosporine; Drug Delivery Systems; Hydrogen-Ion Concentration; Inflammatory Bowel Diseases; Rats; Solubility	2020
Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease. Inflammatory bowel diseases, 2020, 08-20, Volume: 26, Issue:9 Topics: B-Lymphocytes; Biological Products; Cell Line; Cells, Cultured; Cyclosporine; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Leukocytes, Mononuclear; Lymphocyte Activation; Tumor Necrosis Factor Inhibitors	2020
Phospholipid Cyclosporine Prodrugs Targeted at Inflammatory Bowel Disease (IBD) Treatment: Design, Synthesis, and in Vitro Validation. ChemMedChem, 2020, 09-03, Volume: 15, Issue:17 Topics: Cyclosporine; Dose-Response Relationship, Drug; Drug Design; Humans; Hydrolysis; Inflammatory Bowel Diseases; Molecular Structure; Phospholipases A2; Phospholipids; Prodrugs; Structure-Activity Relationship	2020
Postoperative course of laparoscopic subtotal colectomy is affected by prolonged preoperative anti-TNF therapy in patients with acute colitis complicating inflammatory bowel disease. International journal of colorectal disease, 2017, Volume: 32, Issue:10 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Colectomy; Colitis; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Laparoscopy; Male; Middle Aged; Postoperative Complications; Preoperative Care; Steroids; Time Factors; Tumor Necrosis Factor-alpha; Young Adult	2017
Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2017, Volume: 119 Topics: Administration, Oral; Animals; Biological Availability; Colon; Cyclosporine; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Inflammatory Bowel Diseases; Intestinal Mucosa; Lactic Acid; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers	2017
Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease. The American journal of gastroenterology, 2017, Volume: 112, Issue:9 Topics: Adrenal Cortex Hormones; Cyclosporine; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Inflammatory Bowel Diseases; Sweet Syndrome; Young Adult	2017
Cutaneous alternariosis in an immunocompromised dog successfully treated with cold plasma and cessation of immunosuppressive medication. Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere, 2017, Oct-17, Volume: 45, Issue:5 Topics: Alternariosis; Animals; Anti-Inflammatory Agents; Antifungal Agents; Cyclosporine; Dog Diseases; Dogs; Fungicides, Industrial; Imidazoles; Immunocompromised Host; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lymphangiectasis; Male; Plasma Gases; Prednisolone	2017
A refined and translationally relevant model of chronic DSS colitis in BALB/c mice. Laboratory animals, 2018, Volume: 52, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Colitis; Cyclosporine; Dextran Sulfate; Disease Models, Animal; Female; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Thioguanine	2018
New Promising Combo Therapy in Inflammatory Bowel Diseases Refractory to Anti-TNF Agents: Cyclosporine Plus Vedolizumab. Journal of Crohn's & colitis, 2018, Apr-27, Volume: 12, Issue:5 Topics: Antibodies, Monoclonal, Humanized; Cyclosporine; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Remission Induction; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha	2018
Cutaneous side effects caused by treatment for inflammatory bowel disease. Vojnosanitetski pregled, 2016, Volume: 73, Issue:4 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporine; Drug Eruptions; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Tumor Necrosis Factor-alpha	2016
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:3 Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Male; Prospective Studies; Tacrolimus; Treatment Outcome; Young Adult	2019
TNF-α inhibitor-induced psoriasis: A decade of experience at the Cleveland Clinic. Journal of the American Academy of Dermatology, 2020, Volume: 83, Issue:6 Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retrospective Studies; Risk Factors; Sex Factors; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult	2020
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain. Seminars in arthritis and rheumatism, 2015, Volume: 44, Issue:6 Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Inflammatory Bowel Diseases; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Sex Factors; Spain; Spondylarthropathies; Sulfasalazine; Uveitis	2015
Characteristics and outcome of autoimmune liver disease in Asian children. Hepatology international, 2015, Volume: 9, Issue:2 Topics: Adolescent; Anti-Inflammatory Agents; Asian People; Azathioprine; Child; Child, Preschool; Cholangitis, Sclerosing; Cyclosporine; Delayed Diagnosis; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Infant; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Transplantation; Lupus Erythematosus, Systemic; Malaysia; Male; Prednisolone; Retrospective Studies; Survival Rate; Time-to-Treatment; Treatment Outcome	2015
Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN. Inflammatory bowel diseases, 2016, Volume: 22, Issue:6 Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Enteral Nutrition; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Longitudinal Studies; Male; Mesalamine; Retrospective Studies	2016
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2017, Volume: 49, Issue:4 Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicine; Female; Humans; Inflammatory Bowel Diseases; Italy; Mercaptopurine; Methotrexate; Pregnancy; Randomized Controlled Trials as Topic; Treatment Outcome; Tumor Necrosis Factor-alpha	2017
Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients. International journal of dermatology, 2017, Volume: 56, Issue:4 Topics: Adalimumab; Adult; Age Factors; Aged; Arthritis, Rheumatoid; Cyclosporine; Dermatologic Agents; Etanercept; Female; Glucocorticoids; Hematologic Neoplasms; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Middle Aged; Prednisone; Pyoderma Gangrenosum; Retrospective Studies; Sex Factors; Survival Rate	2017
Safety and efficacy of cyclosporine therapy in inflammatory bowel disease. The American journal of gastroenterology, 2008, Volume: 103, Issue:10 Topics: Adult; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Middle Aged; Treatment Outcome	2008
Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease. Inflammatory bowel diseases, 2010, Volume: 16, Issue:8 Topics: Acute Disease; Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cohort Studies; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Female; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Steroids; Treatment Outcome	2010
Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease. Bone marrow transplantation, 2010, Volume: 45, Issue:10 Topics: Animals; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Colitis; Combined Modality Therapy; Cyclosporine; Cytokines; Female; Hematopoietic Stem Cell Transplantation; Immunity, Mucosal; Immunosuppression Therapy; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred BALB C; Severity of Illness Index; Survival Analysis; Trinitrobenzenesulfonic Acid	2010
Assaying macrophage activity in a murine model of inflammatory bowel disease using fluorine-19 MRI. Laboratory investigation; a journal of technical methods and pathology, 2012, Volume: 92, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Colon; Cyclosporine; Dexamethasone; Female; Fluorine; Fluorocarbons; Hyperplasia; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-10; Intestinal Mucosa; Macrophages; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Real-Time Polymerase Chain Reaction	2012
[Effect of immunosuppressants on inflammatory bowel disease: tacrolimus and cyclosporine]. Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 1 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Tacrolimus	2012
Extended abstract: Tacrolimus and cyclosporine in inflammatory bowel disease. Digestive diseases (Basel, Switzerland), 2012, Volume: 30 Suppl 3 Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Inflammatory Bowel Diseases; Infliximab; Polymorphism, Single Nucleotide; Tacrolimus; Treatment Failure	2012
Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice. Life sciences, 2013, Apr-09, Volume: 92, Issue:12 Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents; Budesonide; Colitis; Colon; Cyclosporine; Dextran Sulfate; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Mesalamine; Mice; Mice, Inbred BALB C; Receptors, Prostaglandin E, EP4 Subtype; Thioguanine	2013
The use of ciclosporin in paediatric inflammatory bowel disease: an Italian experience. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:8 Topics: Adolescent; Child; Colectomy; Cyclosporine; Elective Surgical Procedures; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Retrospective Studies; Treatment Failure; Treatment Outcome	2002
Inducing remission in inflammatory bowel disease. Drug and therapeutics bulletin, 2003, Volume: 41, Issue:4 Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Remission Induction	2003
Position statement: immunomodulator therapy for inflammatory Bowel disease. The Israel Medical Association journal : IMAJ, 2003, Volume: 5, Issue:3 Topics: Adjuvants, Immunologic; Azathioprine; Clinical Trials as Topic; Contraindications; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Safety; Tumor Necrosis Factor-alpha	2003
Ten common errors in the management of inflammatory bowel disease. Inflammatory bowel diseases, 2003, Volume: 9, Issue:3 Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Cyclosporine; Humans; Inflammatory Bowel Diseases; Infliximab; Practice Guidelines as Topic; Steroids	2003
Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens. Alimentary pharmacology & therapeutics, 2003, Jul-01, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Tacrolimus	2003
Ultrasonographic detection of toxic megacolon in inflammatory bowel diseases. Digestive diseases and sciences, 2004, Volume: 49, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Megacolon, Toxic; Parenteral Nutrition, Total; Ultrasonography	2004
Circulating levels of cyclosporin A in inflammatory bowel disease: relationships with lymphocyte inhibition and the age of patients. European journal of clinical pharmacology, 2004, Volume: 60, Issue:3 Topics: Administration, Oral; Adult; Cell Division; Cellular Senescence; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Emulsions; Female; Humans; Inflammatory Bowel Diseases; Lymphocyte Activation; Lymphocytes; Male; Middle Aged	2004
[Inflammatory bowel disease and latent thrombocythemia: a novel cause of hepatic vein thrombosis?]. Gastroenterologie clinique et biologique, 2004, Volume: 28, Issue:4 Topics: Adult; Azathioprine; Budd-Chiari Syndrome; Cyclosporine; Female; Fibrinolytic Agents; Heparin; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Thrombocytosis	2004
[Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD]. Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:9 Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Injections, Intramuscular; Male; Mercaptopurine; Methotrexate; Placebos; Pregnancy; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Time Factors	2004
American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology, 2006, Volume: 130, Issue:3 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid	2006
Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. The American journal of gastroenterology, 2008, Volume: 103, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies	2008
Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. International immunopharmacology, 2008, Volume: 8, Issue:6 Topics: Acute Disease; Animals; Antibodies; CD3 Complex; Chronic Disease; Colitis; Cyclosporine; Dextran Sulfate; Disease Models, Animal; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-12 Subunit p40; Methotrexate; Mice; Mice, Inbred C57BL	2008
Cyclosporine therapy for inflammatory bowel disease: definitive answers and remaining questions. Gastroenterology, 1995, Volume: 109, Issue:3 Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Inflammatory Bowel Diseases	1995
Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. Transplantation proceedings, 1993, Volume: 25, Issue:1 Pt 2 Topics: Azathioprine; Cholangitis, Sclerosing; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Transplantation; Male; Middle Aged; Muromonab-CD3; Retrospective Studies; Steroids; Tacrolimus	1993
Cyclosporine and inflammatory bowel disease: still more questions. Gastroenterology, 1995, Volume: 108, Issue:3 Topics: Cyclosporine; Drug Resistance; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Randomized Controlled Trials as Topic; Steroids; Treatment Outcome	1995
Cyclosporine and 6-mercaptopurine in pediatric inflammatory bowel disease. Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates, 1994, Volume: 16, Issue:4 Topics: Child; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Methylprednisolone; Parenteral Nutrition, Total; Sulfasalazine	1994
Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum. The American journal of gastroenterology, 1993, Volume: 88, Issue:1 Topics: Adolescent; Adult; Attitude of Health Personnel; Azathioprine; Child; Colitis; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Gastroenterology; Health Surveys; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methotrexate; Pediatrics; Remission Induction; Retrospective Studies; Societies, Medical; Surveys and Questionnaires	1993
The simultaneous treatment of inflammatory bowel diseases and associated pyoderma gangrenosum with oral cyclosporin A. Scandinavian journal of gastroenterology, 1999, Volume: 34, Issue:2 Topics: Adult; Aged; Cyclosporine; Dermatologic Agents; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Middle Aged; Pyoderma Gangrenosum	1999
More evidence of the failure of oral cyclosporine to maintain remission due to intravenous cyclosporine in IBD. Journal of clinical gastroenterology, 1999, Volume: 29, Issue:2 Topics: Administration, Oral; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infusions, Intravenous; Recurrence; Treatment Failure	1999
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology, 2000, Volume: 118, Issue:2 Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Colectomy; Colon; Cyclosporine; Female; Flow Cytometry; Genes, MDR; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Lymphocytes; Male; Mesalamine; Methotrexate; Middle Aged; Reference Values; Treatment Failure	2000
IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases. European journal of gastroenterology & hepatology, 2000, Volume: 12, Issue:1 Topics: Azathioprine; Cyclosporine; Europe; Female; Gastroenterology; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Internal Medicine; Male; Mercaptopurine; Methotrexate; North America; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications; Surveys and Questionnaires	2000
Does cyclosporin A worsen liver function in patients with inflammatory bowel disease and total parenteral nutrition? Revista espanola de enfermedades digestivas, 2000, Volume: 92, Issue:2 Topics: Adult; Chemical and Drug Induced Liver Injury; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Diseases; Liver Function Tests; Male; Parenteral Nutrition, Total; Retrospective Studies	2000
Audit of cyclosporin use in inflammatory bowel disease: limited benefits, numerous side-effects. European journal of gastroenterology & hepatology, 2000, Volume: 12, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Middle Aged; Retrospective Studies	2000
Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Inflammatory bowel diseases, 2001, Volume: 7, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Mercaptopurine; Middle Aged; Pyoderma Gangrenosum; Retrospective Studies; Treatment Outcome	2001
Pharmacokinetics of cyclosporin microemulsion in patients with inflammatory bowel disease. Clinical pharmacokinetics, 2001, Volume: 40, Issue:6 Topics: Adolescent; Adult; Analysis of Variance; Area Under Curve; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Dose-Response Relationship, Drug; Emulsions; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Middle Aged	2001
Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology, 1992, Volume: 102, Issue:2 Topics: Aminosalicylic Acids; Cyclosporine; Fluorescent Antibody Technique; Granulocyte Colony-Stimulating Factor; Growth Substances; Humans; Hydrocortisone; Inflammatory Bowel Diseases; Interleukins; Intestinal Mucosa; Mesalamine; Neutrophils; RNA Probes; RNA, Messenger	1992
IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons. Clinical and experimental immunology, 1992, Volume: 88, Issue:1 Topics: Aminosalicylic Acids; Colonic Neoplasms; Cyclosporine; Humans; Hydrocortisone; Inflammatory Bowel Diseases; Interleukin-2; Intestinal Mucosa; Leukocytes, Mononuclear; Mesalamine	1992